Form 8-K ALNYLAM PHARMACEUTICALS, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Alnylam secures $500 million revolving credit facility
October 3, 2025 4:19 PM EDTAlnylam Pharmaceuticals Inc. (NASDAQ: ALNY) entered into a $500 million revolving credit agreement on September 30, 2025, with Bank of America N.A. serving as administrative agent.
The revolving credit facility includes a $150 million letter of credit sublimit and allows the company to use proceeds for working capital and general... More
